Human papilloma virus: A new risk factor in a subset of head and neck cancers

Journal of Cancer Research and Therapeutics

Volumn 7, Issue 3, 2011, Pages 251-255

  Bisht, Manisha ^a   Bist, Sampan Singh ^a  

^a HIMALAYAN INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Human papilloma virus; oropharyngeal carcinoma; squamous cell carcinoma

Indexed keywords

COMPLEMENTARY RNA; SMALL INTERFERING RNA; WART VIRUS VACCINE;

CANCER GENE THERAPY; CLINICAL DECISION MAKING; HEAD AND NECK CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MALIGNANT TRANSFORMATION; NONHUMAN; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PROGNOSIS; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS STRAIN; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RISK FACTORS; TONSILLAR NEOPLASMS; TUMOR VIRUS INFECTIONS;

EID: 81855206624     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.87004     Document Type: Review

References (34)

1. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002: Cancer incidence and Prevalence worldwide. IARC Cancer Base no. 5, version 2.0. Lyon, France: IARC; 2004.
2. Loning T, Ikenberg H, Becker J, Gissmann L, Hoepfer I, Zur Hausen H. Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol 1985;84:417-20. (Pubitemid 15056667)
3. Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002;8:3187-92. (Pubitemid 35155029)
4. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical and molecular entity. Semin Oncol 2004;31:744-54. (Pubitemid 39602680)
5. Dahistrand H, Dahlgren L, Lindquist D, Munck-Wikland E, Dalianis T. Presence of Human papillomavirus in tonsillar cancer is a favorable prognostic factor for clinical outcome. Anticancer Res 2004;24:1829-35. (Pubitemid 38954596)
6. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 1995;64:1-378.
7. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36. (Pubitemid 120035062)
8. Boyer SN, Wazer DE, Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 1996;56:4620-4. (Pubitemid 26338060)
9. Sidransky D. Molecular genetics of head and neck cancer. Curr Opin Oncol 1995;7:229-33.
10. Wittenkindt C, Gultekin E, Weissenborn SJ, Dienes HP, Pfister HJ, Klussmann JP. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival. Adv Otorhinolaryngol 2005;62:72-80.
11. Dahlgren L, Dahistrand H, Lindquist D, Högmo, A, Björnestål L, Lindholm J, et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is favourable prognostic factor in base of tongue cancer patients. Int J Cancer 2004;112:1015-9. (Pubitemid 39507008)
12. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467-75. (Pubitemid 40270113)
13. Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, et al. Molecular classification identifies a subset of human papillomavirus- associated oropharyngeal cancers with favourable prognosis. J Clin Oncol 2006;24:736-47. (Pubitemid 46622040)
14. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicentre study. J Natl Cancer Inst 2003;95:1772-83. (Pubitemid 38008900)
15. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56. (Pubitemid 46740304)
16. Rintala M, Grénman S, Puranen M, Syrjänen S. Natural history of oral human papillomasvirus infections in female and male partners: A prospective Finnish HPV Family Study. J Clin Virol 2006;35:89-94. (Pubitemid 43020959)
17. McNeil C. Human papillomavirus in oropharyngeal cancers: New data inspire hope for vaccines. J Natl Cancer Inst 2000;92:680-1.
18. Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006;119:2620-3. (Pubitemid 44691317)
19. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125-31. (Pubitemid 32285233)
20. Lawton G, Thomas S, Schonrock J, Monsour F, Frazer I. Human papillomaviruses in normal oral mucosa: A comparison of methods for sample collection. J Oral Pathol Med 1992;21:265-9.
21. Heath EM, Morken NW, Campbell KA, Tkach D, Boyd EA, Strom DA. Use of buccal cells collected in mouthwash as a source of DNA for clinical testing. Arch Pathol Lab Med 2001;125:127-33. (Pubitemid 32096197)
22. Ha PK, Califano JA. The role of human papillomavirus in oral carcinogenesis. Crit Rev Oral Biol Med 2004;15:188-96. (Pubitemid 44560780)
23. Perrone F, Gloghini A, Cortelazzi B, Bossi P, Licitra L, Pilotti S. Isolating p16-positive/HPV-negative Oropharyngeal Cancer: An Effort Worth Making. Am J Surg Pathol 2011;35:774-7.
24. El-Mofty SK. Human papillomavirus (HPV) related carcinomas of the upper aerodigestive tract. Head Neck Pathol 2007;1:181-5.
25. Termine N, Giovannelli L, Rinaldi G, Campisi G. Human papillomavirus infection and head and neck squamous cell carcinoma: Current debates. J Stomatol Invest 2008;2:27-33.
26. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: A radiosensitive subgroup of head and neck carcinoma. Cancer 2001;92:805-13. (Pubitemid 32783066)
27. Slaughter DP, Southwick H, Smejkol W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953;6:963-8.
28. Hoffmann TK, Sonkoly E, Hauser U, Van Lierop A, Whiteside TL, Klussmann JP, et al. Alterations in the p53 pathway and their association with radio-and chemosensitivity in head and neck squamous cell carcinoma. Oral Oncol 2008;44:1100-9.
29. Smith EM, Rubenstein LM, Hoffman H, Haugen TH, Turek LP. Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infect Agent Cancer 2010;5:4
30. Garland SM, Hernandez AM, Wheeler CM, Perez G, Harper DM, Leodolter S, et al. Females united to unilaterally reduce endo/ecto cervical disease (FUTURE-I) investigators: Qudrivalent vaccine against Human papillomaviruses to prevent anogenital diseases. N Engl J Med 2007;356:1928-43.
31. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy upto 4.5 years of a bivalent L1 virus like particle vaccine against Human papillomavirus types 16 and18: Follow up from a randomized control trial. Lancet 2006;367:1247-55.
32. Borysiewicz LK, Fiander A, Nimako M, Man S, Wilkinson GW, Westmoreland D, et al. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 1996;347:1523-7. (Pubitemid 26162644)
33. Yamoto K, Yamada T, Kizaki M, Ui Tei K, Natori Y, Fujino M, et al. New highly potent and specific E6 andE7 siRNAs for treatment of HPV 16 positive cervical cancer. Cancer Gene Ther 2008;15:140-53. (Pubitemid 351240669)
34. Green KL, Brown C, Roeder GE, Southgate TD, Gaston K. A cancer cell specific inducer of apoptosis. Hum Gene Ther 2007;18:547-61. (Pubitemid 47036048)